Back to search

Article

Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer

2020-02-06

Abstract excerpt

<h4>Background: </h4> Triple negative breast cancer (TNBC) is a heterogeneous disease with more aggressive clinical courses than other subtypes of breast cancer. In this study, we performed high-resolution mass spectrometry-based quantitative proteomics with TNBC clinical tissue specimens to explore the early and sensitive diagnostic signatures and potential therapeutic targets for TNBC patients. Methods We perfor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c9d2c68-54c6-5d44-9c5a-e0634e86d889
DOI
10.21203/rs.2.22780/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancerDOI 10.21203/rs.2.22780/v1
Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancerSemantic proximity
Quantitative proteomics analysis of triple-negative breast cancersSemantic proximity
The Proteomic Landscape of Triple-Negative Breast CancerSemantic proximity
Differentially Expressed Genes and Key Pathways in Triple Negative Breast Cancers: A Bioinformatics AnalysisSemantic proximity
Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersSemantic proximity
High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratificationSemantic proximity
Comprehensive proteome and phosphoproteome analysis reveals the protein characterization of invasive ductal and lobular carcinoma with specific molecular subgroupSemantic proximity
Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics AnalysisSemantic proximity
Development of a novel lipid metabolism-based signature to predict survival and immune response in triple negative breast cancerSemantic proximity
Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniquesSemantic proximity
MIR4435-2HG: A Novel Biomarker for Triple-Negative Breast Cancer Diagnosis and Prognosis, Driving Tumor Progression through EMT by JNK/c-Jun and p38 MAPK Signaling Pathway ActivationSemantic proximity
Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving PathwaysSemantic proximity
Select a neighboring publication to make it the new centre.